Diabetes Care Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

The Global Diabetes Care Devices Market was estimated at USD 53.5 billion in 2024 and is expected to grow from USD 59.2 billion in 2025 to USD 167.5 billion by 2034, at a CAGR of 12.2%, according to the latest report published by Global Market Insights Inc.

The increasing awareness of the long-term complications associated with uncontrolled diabetes, such as cardiovascular disease, kidney failure, and neuropathy, is pushing patients and healthcare systems to adopt technology-driven solutions for early detection and consistent disease monitoring.

Rising Adoption of Devices

The devices segment held a notable share in 2024, encompassing blood glucose meters, test strips, insulin pens, insulin pumps, and continuous glucose monitoring (CGM) systems. Companies are responding by introducing localized, cost-effective devices with smart features such as Bluetooth connectivity and mobile app integration. To strengthen their foothold, leading players are forming partnerships with local distributors, expanding regional manufacturing, and customizing product lines to meet cultural and economic preferences in urban and rural markets alike.

Homecare to Gain Traction

The homecare segment generated a significant share in 2024 as more patients shifted toward self-management and at-home monitoring. Factors such as the rising cost of in-clinic care, growing health consciousness, and the increasing prevalence of type 2 diabetes among middle-aged adults have all contributed to this trend. Companies are prioritizing ease of use, portability, and affordability while ensuring accuracy and reliability. Key strategies to capture this segment include launching direct-to-consumer online platforms, offering multilingual user support, and partnering with digital health apps to deliver personalized insights and remote monitoring capabilities.

North America to Emerge as a Propelling Region

North America diabetes care devices market held a notable share in 2024, driven by high disease prevalence, strong healthcare infrastructure, and widespread adoption of advanced monitoring technologies. The United States accounts for the largest share, with rising rates of both Type 1 and Type 2 diabetes spurring demand for accurate, real-time monitoring and insulin delivery systems. Growing patient awareness, favorable reimbursement policies, and increasing use of digital health platforms are accelerating the uptake of continuous glucose monitors (CGMs), insulin pumps, and connected mobile apps.

Major players in the diabetes care devices market are Dr. Reddy’s Laboratories, Bionime, Insulet, Sanofi, ARKRAY, Tandem Diabetes Care, Dexcom, Ypsomed Holding, F. Hoffmann-La Roche, Medtronic, Pendiq, B. Braun Melsungen, Ascensia Diabetes Care, Eli Lilly and Company, Novo Nordisk, LifeScan, Nova Biomedical, Sinocare, Abbott Laboratories, DarioHealth, Becton, Dickinson and Company.

To strengthen their position, leading players in the diabetes care devices market are investing heavily in product innovation, digital integration, and strategic collaborations. Many are introducing AI-powered features and app-based platforms that offer personalized insights, enabling better self-management and real-time feedback. Companies are also focusing on miniaturization and non-invasive technology to improve user comfort and adherence. Strategic partnerships with healthcare providers, insurance companies, and tech firms are becoming essential to expand distribution and enhance patient outcomes.

Comprehensive Market Analysis and Forecast

• Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
• Competitive landscape with Porter’s Five Forces and PESTEL analysis
• Market size, segmentation, and regional forecasts
• In-depth company profiles, business strategies, financial insights, and SWOT analysis

This product will be delivered within 2-4 business days.